Label-free mass spectrometry-based proteomics for biomarker discovery and validation

References

• Boja ES, Rodriguez H. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science. Korean J. Lab. Med.31(2), 61–71 (2011).
   PubMedGoogle Scholar
• Rifai N, Gillette MA, Carr SA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol.24(8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang Q, Faca V, Hanash S. Mining the plasma proteome for disease applications across seven logs of protein abundance. J. Proteome Res.10(1), 46–50 (2011).
   PubMed Web of Science ®Google Scholar
• Simpson RJ, Bernhard OK, Greening DW, Moritz RL. Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol.12(1), 72–77 (2008).
   PubMed Web of Science ®Google Scholar
• Rajcevic U, Niclou SP, Jimenez CR. Proteomics strategies for target identification and biomarker discovery in cancer. Front. Biosci.14, 3292–3303 (2009).
   Web of Science ®Google Scholar
• Surinova S, Schiess R, Huttenhain R, Cerciello F, Wollscheid B, Aebersold R. On the development of plasma protein biomarkers. J. Proteome Res.10(1), 5–16 (2011).
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu. Rev. Biochem.80, 273–299 (2011).
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Asnani A, Carr SA. Status and prospects for discovery and verification of new biomarkers of cardiovascular disease by proteomics. Circ. Res.109(4), 463–474 (2011).
   PubMed Web of Science ®Google Scholar
• Wisniewski JR, Ostasiewicz P, Mann M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J. Proteome Res.10(7), 3040–3049 (2011).
   PubMed Web of Science ®Google Scholar
• Hartwell L, Mankoff D, Paulovich A, Ramsey S, Swisher E. Cancer biomarkers: a systems approach. Nat. Biotechnol.24(8), 905–908 (2006).
   PubMed Web of Science ®Google Scholar
• Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J. Clin. Oncol.28(4), 698–704 (2010).
   PubMed Web of Science ®Google Scholar
• Whiteaker JR, Lin C, Kennedy J et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol.29(7), 625–634 (2011).
   PubMed Web of Science ®Google Scholar
• Jimenez CR, Piersma S, Pham TV. High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery. Biomark. Med.1(4), 541–565 (2007).
   PubMed Web of Science ®Google Scholar
• Neilson KA, Ali NA, Muralidharan S et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics11(4), 535–553 (2011).
   PubMed Web of Science ®Google Scholar
• Ong SE, Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol.1(5), 252–262 (2005).
   PubMed Web of Science ®Google Scholar
• Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: a critical review. Anal. Bioanal. Chem.389(4), 1017–1031 (2007).
   PubMed Web of Science ®Google Scholar
• Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1(5), 376–386 (2002).
   PubMed Web of Science ®Google Scholar
• Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics3(12), 1154–1169 (2004).
   PubMed Web of Science ®Google Scholar
• Thompson A, Schafer J, Kuhn K et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem.75(8), 1895–1904 (2003).
   PubMed Web of Science ®Google Scholar
• Hsu JL, Huang SY, Chow NH, Chen SH. Stable-isotope dimethyl labeling for quantitative proteomics. Anal. Chem.75(24), 6843–6852 (2003).
   PubMed Web of Science ®Google Scholar
• Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl Acad. Sci. USA100(12), 6940–6945 (2003).
   PubMed Web of Science ®Google Scholar
• Beynon RJ, Doherty MK, Pratt JM, Gaskell SJ. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods2(8), 587–589 (2005).
   PubMed Web of Science ®Google Scholar
• Levin Y, Schwarz E, Wang L, Leweke FM, Bahn S. Label-free LC–MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J. Sep. Sci.30(14), 2198–2203 (2007).
   PubMed Web of Science ®Google Scholar
• Piersma SR, Fiedler U, Span S et al. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J. Proteome Res.9(4), 1913–1922 (2010).
   PubMed Web of Science ®Google Scholar
• Albrethsen J, Knol JC, Piersma SR et al. Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression. Mol. Cell. Proteomics9(5), 988–1005 (2010).
   PubMed Web of Science ®Google Scholar
• Fratantoni SA, Piersma SR, Jimenez CR. Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: evaluation of sensitivity and reproducibility of CSF analysis using GeLC–MS/MS and spectral counting. Proteomics Clin. Appl.4(6–7), 613–617 (2010).
   PubMed Web of Science ®Google Scholar
• Collier TS, Sarkar P, Franck WL, Rao BM, Dean RA, Muddiman DC. Direct comparison of stable isotope labeling by amino acids in cell culture and spectral counting for quantitative proteomics. Anal. Chem.82(20), 8696–8702 (2010).
   PubMed Web of Science ®Google Scholar
• Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE. Comprehensive label-free method for the relative quantification of proteins from biological samples. J. Proteome Res.4(4), 1442–1450 (2005).
   PubMed Web of Science ®Google Scholar
• Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem.76(14), 4193–4201 (2004).
   PubMed Web of Science ®Google Scholar
• Old WM, Meyer-Arendt K, Aveline-Wolf L et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell. Proteomics4(10), 1487–1502 (2005).
   PubMed Web of Science ®Google Scholar
• Collier TS, Randall SM, Sarkar P, Rao BM, Dean RA, Muddiman DC. Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. Rapid Commun. Mass Spectrom.25(17), 2524–2532 (2011).
   PubMed Web of Science ®Google Scholar
• Asara JM, Christofk HR, Freimark LM, Cantley LC. A label-free quantification method by MS/MS TIC compared to SILAC and spectral counting in a proteomics screen. Proteomics8(5), 994–999 (2008).
   PubMed Web of Science ®Google Scholar
• Griffin NM, Yu J, Long F et al. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat. Biotechnol.28(1), 83–89 (2010).
   PubMed Web of Science ®Google Scholar
• Bellew M, Coram M, Fitzgibbon M et al. A suite of algorithms for the comprehensive analysis of complex protein mixtures using high-resolution LC–MS. Bioinformatics22(15), 1902–1909 (2006).
   PubMed Web of Science ®Google Scholar
• Voss B, Hanselmann M, Renard BY et al. SIMA: simultaneous multiple alignment of LC/MS peak lists. Bioinformatics27(7), 987–993 (2011).
   PubMed Web of Science ®Google Scholar
• Jaffe JD, Mani DR, Leptos KC, Church GM, Gillette MA, Carr SA. PEPPeR, a platform for experimental proteomic pattern recognition. Mol. Cell. Proteomics5(10), 1927–1941 (2006).
   PubMed Web of Science ®Google Scholar
• Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol.26(12), 1367–1372 (2008).
   PubMed Web of Science ®Google Scholar
• Khan Z, Bloom JS, Garcia BA, Singh M, Kruglyak L. Protein quantification across hundreds of experimental conditions. Proc. Natl Acad. Sci. USA106(37), 15544–15548 (2009).
   PubMed Web of Science ®Google Scholar
• Tsou CC, Tsai CF, Tsui YH et al. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol. Cell. Proteomics9(1), 131–144 (2010).
   PubMed Web of Science ®Google Scholar
• Hoehenwarter W, Wienkoop S. Spectral counting robust on high mass accuracy mass spectrometers. Rapid Commun. Mass Spectrom.24(24), 3609–3614 (2010).
   PubMed Web of Science ®Google Scholar
• Paoletti AC, Parmely TJ, Tomomori-Sato C et al. Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl Acad. Sci. USA103(50), 18928–18933 (2006).
   PubMed Web of Science ®Google Scholar
• Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res.5(9), 2339–2347 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wen Z, Washburn MP, Florens L. Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. Anal. Chem.82(6), 2272–2281 (2010).
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B57, 289–300 (1995).
   Google Scholar
• Quackenbush J. Computational analysis of microarray data. Nat. Rev. Genet.2(6), 418–427 (2001).
   PubMed Web of Science ®Google Scholar
• Pham TV, Piersma SR, Warmoes M, Jimenez CR. On the β-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics26(3), 363–369 (2010).
   PubMed Web of Science ®Google Scholar
• Booth JG, Eilertson KE, Olinares PD, Yu H. A bayesian mixture model for comparative spectral count data in shotgun proteomics. Mol. Cell. Proteomics10(8), M110.007203 (2011).
   PubMed Web of Science ®Google Scholar
• Choi H, Fermin D, Nesvizhskii AI. Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell. Proteomics7(12), 2373–2385 (2008).
   PubMed Web of Science ®Google Scholar
• Dudoit S, Shaffer JP, Boldrick JC. Multiple hypothesis testing in microarray experiments. Stat. Sci.18, 71–103 (2003).
   Web of Science ®Google Scholar
• Oberg AL, Vitek O. Statistical design of quantitative mass spectrometry-based proteomic experiments. J. Proteome Res.8(5), 2144–2156 (2009).
   PubMed Web of Science ®Google Scholar
• Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol.4, 222 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell. Proteomics5(4), 573–588 (2006).
   PubMed Web of Science ®Google Scholar
• Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics6(12), 2212–2229 (2007).
   PubMed Web of Science ®Google Scholar
• Addona TA, Abbatiello SE, Schilling B et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat. Biotechnol.27(7), 633–641 (2009).
   PubMed Web of Science ®Google Scholar
• Zhi W, Wang M, She JX. Selected reaction monitoring (SRM) mass spectrometry without isotope labeling can be used for rapid protein quantification. Rapid Commun. Mass Spectrom.25(11), 1583–1588 (2011).
   PubMed Web of Science ®Google Scholar
• Balasubramaniam D, Eissler CL, Stauffacher CV, Hall MC. Use of selected reaction monitoring data for label-free quantification of protein modification stoichiometry. Proteomics10(23), 4301–4305 (2010).
   PubMed Web of Science ®Google Scholar
• Elschenbroich S, Kislinger T. Targeted proteomics by selected reaction monitoring mass spectrometry: applications to systems biology and biomarker discovery. Mol. Biosyst.7(2), 292–303 (2011).
   PubMedGoogle Scholar
• Huttenhain R, Malmstrom J, Picotti P, Aebersold R. Perspectives of targeted mass spectrometry for protein biomarker verification. Curr. Opin. Chem. Biol.13(5–6), 518–525 (2009).
   PubMed Web of Science ®Google Scholar
• Maclean B, Tomazela DM, Shulman N et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics26(7), 966–968 (2010).
   PubMed Web of Science ®Google Scholar
• Stergachis AB, Maclean B, Lee K, Stamatoyannopoulos JA, Maccoss MJ. Rapid empirical discovery of optimal peptides for targeted proteomics. Nat. Methods8(12), 1041–1043 (2011).
   PubMed Web of Science ®Google Scholar
• Picotti P, Bodenmiller B, Mueller LN, Domon B, Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell138(4), 795–806 (2009).
   PubMed Web of Science ®Google Scholar
• Warmoes M, Jaspers JE, Pham TV et al. Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with diagnostic and prognostic value in human breast cancer. Mol. Cell. Proteomics doi:10.1074/mcp.M111.013334 (2012) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Addona TA, Shi X, Keshishian H et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. Nat. Biotechnol.29(7), 635–643 (2011).
   PubMed Web of Science ®Google Scholar
• Tabata T, Sato T, Kuromitsu J, Oda Y. Pseudo internal standard approach for label-free quantitative proteomics. Anal. Chem.79(22), 8440–8445 (2007).
   PubMed Web of Science ®Google Scholar
• Bluemlein K, Ralser M. Monitoring protein expression in whole-cell extracts by targeted label- and standard-free LC–MS/MS. Nat. Protoc.6(6), 859–869 (2011).
   PubMed Web of Science ®Google Scholar
• Choi S, Kim J, Yea K, Suh PG, Kim J, Ryu SH. Targeted label-free quantitative analysis of secretory proteins from adipocytes in response to oxidative stress. Anal. Biochem.401(2), 196–202 (2010).
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu Q, Zimmerman LJ et al. Methods for peptide and protein quantitation by liquid chromatography–multiple reaction monitoring mass spectrometry. Mol. Cell. Proteomics10(6), M110.006593 (2011).
   PubMed Web of Science ®Google Scholar
• Park J, Cha DH, Lee SJ, Kim YN, Kim YH, Kim KP. Discovery of the serum biomarker proteins in severe preeclampsia by proteomic analysis. Exp. Mol. Med.43(7), 427–435 (2011).
   PubMed Web of Science ®Google Scholar
• Turtoi A, Mazzucchelli GD, De PE. Isotope coded protein label quantification of serum proteins – comparison with the label-free LC–MS and validation using the MRM approach. Talanta80(4), 1487–1495 (2010).
   PubMed Web of Science ®Google Scholar
• Cima I, Schiess R, Wild P et al. Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer. Proc. Natl Acad. Sci. USA108(8), 3342–3347 (2011).
   PubMed Web of Science ®Google Scholar
• Fugmann T, Borgia B, Revesz C et al. Proteomic identification of vanin-1 as a marker of kidney damage in a rat model of type 1 diabetic nephropathy. Kidney Int.80(3), 272–281 (2011).
   PubMed Web of Science ®Google Scholar
• Zhou JY, Afjehi-Sadat L, Asress S et al. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J. Proteome Res.9(10), 5133–5141 (2010).
   PubMed Web of Science ®Google Scholar
• De Wit M, Jimenez CR, Carvalho B et al. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression. Gut doi:10.1136/gutjnl-2011-300511 (2011) (Epub ahead of print).
   Google Scholar
• Alldridge L, Metodieva G, Greenwood C et al. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J. Proteome Res.7(4), 1458–1469 (2008).
   PubMed Web of Science ®Google Scholar
• May D, Pan S, Crispin DA et al. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics. J. Proteome Res.10(1), 200–209 (2011).
   PubMed Web of Science ®Google Scholar
• Gromov P, Gromova I, Bunkenborg J et al. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol. Oncol.4(1), 65–89 (2010).
   PubMed Web of Science ®Google Scholar
• Han CL, Chen JS, Chan EC et al. An informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Mol. Cell. Proteomics.10(4), M110.003087 (2011).
   PubMed Web of Science ®Google Scholar
• Conrotto P, Roesli C, Rybak J et al. Identification of new accessible tumor antigens in human colon cancer by ex vivo protein biotinylation and comparative mass spectrometry analysis. Int. J. Cancer123(12), 2856–2864 (2008).
   PubMed Web of Science ®Google Scholar
• Hyung SW, Lee MY, Yu JH et al. A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers. Mol. Cell. Proteomics10(10), M111.011023 (2011).
   PubMed Web of Science ®Google Scholar
• Rikova K, Guo A, Zeng Q et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell131(6), 1190–1203 (2007).
   PubMed Web of Science ®Google Scholar
• Han CL, Chien CW, Chen WC et al. A multiplexed quantitative strategy for membrane proteomics: opportunities for mining therapeutic targets for autosomal dominant polycystic kidney disease. Mol. Cell. Proteomics7(10), 1983–1997 (2008).
   PubMed Web of Science ®Google Scholar
• Pan S, Chen R, Aebersold R, Brentnall TA. Mass spectrometry based glycoproteomics–from a proteomics perspective. Mol. Cell. Proteomics10(1), R110.003251 (2011).
   PubMed Web of Science ®Google Scholar
• Strassberger V, Fugmann T, Neri D, Roesli C. Chemical proteomic and bioinformatic strategies for the identification and quantification of vascular antigens in cancer. J. Proteomics73(10), 1954–1973 (2010).
   PubMed Web of Science ®Google Scholar
• Rush J, Moritz A, Lee KA et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol.23(1), 94–101 (2005).
   PubMed Web of Science ®Google Scholar
• Gu TL, Deng X, Huang F et al. Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PLoS One6(1), e15640 (2011).
   PubMed Web of Science ®Google Scholar
• Gutstein HB, Morris JS. Laser capture sampling and analytical issues in proteomics. Expert Rev. Proteomics4(5), 627–637 (2007).
   PubMed Web of Science ®Google Scholar
• Xu BJ. Combining laser capture microdissection and proteomics: methodologies and clinical applications. Proteomics Clin. Appl.4(2), 116–123 (2010).
   PubMed Web of Science ®Google Scholar
• Thakur D, Rejtar T, Wang D et al. Microproteomic analysis of 10,000 laser captured microdissected breast tumor cells using short-range sodium dodecyl sulfate-polyacrylamide gel electrophoresis and porous layer open tubular liquid chromatography tandem mass spectrometry. J. Chromatogr. A1218(45), 8168–8174 (2011).
   PubMed Web of Science ®Google Scholar
• Hill JJ, Tremblay TL, Pen A et al. Identification of vascular breast tumor markers by laser capture microdissection and label-free LC–MS. J. Proteome Res.10(5), 2479–2493 (2011).
   PubMed Web of Science ®Google Scholar
• Braakman RB, Tilanus-Linthorst MM, Liu NQ et al. Optimized nLC–MS workflow for laser capture microdissected breast cancer tissue. J. Proteomics doi:10.1016/j.jprot.2012.01.022 (2012) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Tanca A, Pagnozzi D, Addis MF. Setting proteins free: Progresses and achievements in proteomics of formalin-fixed, paraffin-embedded tissues. Proteomics Clin. Appl.6(1–2), 7–21 (2011).
   PubMed Web of Science ®Google Scholar
• Ostasiewicz P, Zielinska DF, Mann M, Wisniewski JR. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J. Proteome Res.9(7), 3688–3700 (2010).
   PubMed Web of Science ®Google Scholar
• Negishi A, Masuda M, Ono M et al. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci.100(9), 1605–1611 (2009).
   PubMed Web of Science ®Google Scholar
• Pan S, Chen R, Stevens T et al. Proteomics portrait of archival lesions of chronic pancreatitis. PLoS One6(11), e27574 (2011).
   PubMed Web of Science ®Google Scholar
• Bell LN, Saxena R, Mattar SG, You J, Wang M, Chalasani N. Utility of formalin-fixed, paraffin-embedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis. Proteomics Clin. Appl.5(7–8), 397–404 (2011).
   PubMed Web of Science ®Google Scholar
• Nirmalan NJ, Hughes C, Peng J et al. Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J. Proteome Res.10(2), 896–906 (2011).
   PubMed Web of Science ®Google Scholar
• Tanca A, Addis MF, Pagnozzi D et al. Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archives. J. Proteomics74(3), 359–370 (2011).
   PubMed Web of Science ®Google Scholar
• Sprung RW, Brock JW, Tanksley JP et al. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol. Cell. Proteomics8(8), 1988–1998 (2009).
   PubMed Web of Science ®Google Scholar
• Tanca A, Pagnozzi D, Falchi G et al. Impact of fixation time on GeLC–MS/MS proteomic profiling of formalin-fixed, paraffin-embedded tissues. J. Proteomics74(7), 1015–1021 (2011).
   PubMed Web of Science ®Google Scholar
• Teng PN, Bateman NW, Hood BL, Conrads TP. Advances in proximal fluid proteomics for disease biomarker discovery. J. Proteome Res.9(12), 6091–6100 (2010).
   PubMed Web of Science ®Google Scholar
• Kim MJ, Frankel AH, Tam FW. Urine proteomics and biomarkers in renal disease. Nephron Exp. Nephrol.119(1), E1–E7 (2011).
   PubMedGoogle Scholar
• Filiou MD, Turck CW, Martins-de-Souza D. Quantitative proteomics for investigating psychiatric disorders. Proteomics Clin. Appl.5(1–2), 38–49 (2011).
   PubMed Web of Science ®Google Scholar
• Liang CR, Tan S, Tan HT et al. Proteomic analysis of human gastric juice: a shotgun approach. Proteomics10(21), 3928–3931 (2010).
   PubMed Web of Science ®Google Scholar
• Soltermann A, Ossola R, Kilgus-Hawelski S et al.N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer114(2), 124–133 (2008).
   PubMed Web of Science ®Google Scholar
• Yu CJ, Wang CL, Wang CI et al. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology. J. Proteome Res.10(10), 4671–4682 (2011).
   PubMed Web of Science ®Google Scholar
• Haslene-Hox H, Oveland E, Berg KC et al. A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue. PLoS One6(4), e19217 (2011).
   PubMed Web of Science ®Google Scholar
• Kosanam H, Makawita S, Judd B, Newman A, Diamandis EP. Mining the malignant ascites proteome for pancreatic cancer biomarkers. Proteomics11(23), 4551–4558 (2011).
   PubMed Web of Science ®Google Scholar
• Farid SG, Craven RA, Peng J et al. Shotgun proteomics of human bile in hilar cholangiocarcinoma. Proteomics11(10), 2134–2138 (2011).
   PubMed Web of Science ®Google Scholar
• Drake RR, Elschenbroich S, Lopez-Perez O et al. In-depth proteomic analyses of direct expressed prostatic secretions. J. Proteome Res.9(5), 2109–2116 (2010).
   PubMed Web of Science ®Google Scholar
• Tan S, Liang CR, Yeoh KG, So J, Hew CL, Chung MC. Gastrointestinal fluids proteomics. Proteomics Clin. Appl.1(8), 820–833 (2007).
   PubMed Web of Science ®Google Scholar
• Hitti J, Lapidus JA, Lu X et al. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am. J. Obstet. Gynecol.203(1), 32–38 (2010).
   PubMed Web of Science ®Google Scholar
• Cutillas PR, Chalkley RJ, Hansen KC et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am. J. Physiol. Renal Physiol.287(3), F353–F364 (2004).
   PubMed Web of Science ®Google Scholar
• Morales DM, Townsend RR, Malone JP et al. Alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with post-hemorrhagic hydrocephalus of prematurity. Mol. Cell. ProteomicsM111.011973 (2011).
   Google Scholar
• Schutzer SE, Angel TE, Liu T et al. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One6(2), e17287 (2011).
   PubMed Web of Science ®Google Scholar
• Zoidakis J, Makridakis M, Zerefos PG et al. Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol. Cell. Proteomics11(4), M111.009449 (2011) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Rao PV, Reddy AP, Lu X et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res.8(1), 239–245 (2009).
   PubMed Web of Science ®Google Scholar
• Amon LM, Law W, Fitzgibbon MP et al. Integrative proteomic analysis of serum and peritoneal fluids helps identify proteins that are up-regulated in serum of women with ovarian cancer. PLoS One5(6), e11137 (2010).
   Google Scholar
• Pan J, Chen HQ, Sun YH, Zhang JH, Luo XY. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology. Lung186(4), 255–261 (2008).
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang Y, Zhang A et al. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology. OMICS13(4), 291–300 (2009).
   PubMed Web of Science ®Google Scholar
• Beer LA, Tang HY, Barnhart KT, Speicher DW. Plasma biomarker discovery using 3D protein profiling coupled with label-free quantitation. Methods Mol. Biol.728, 3–27 (2011).
   PubMedGoogle Scholar
• Beer LA, Tang HY, Sriswasdi S, Barnhart KT, Speicher DW. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J. Proteome Res.10(3), 1126–1138 (2011).
   PubMed Web of Science ®Google Scholar
• Tang HY, Beer LA, Chang-Wong T et al. A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer. J. Proteome Res.11(2), 678–691 (2012).
   PubMed Web of Science ®Google Scholar
• Fatima N, Chelius D, Luke BT et al. Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients. Cancer Genomics Proteomics6(1), 41–49 (2009).
   PubMedGoogle Scholar
• Metodieva G, Greenwood C, Alldridge L, Sauven P, Metodiev M. A peptide-centric approach to breast cancer biomarker discovery utilizing label-free multiple reaction monitoring mass spectrometry. Proteomics Clin. Appl.3(1), 78–82 (2009).
   PubMed Web of Science ®Google Scholar
• Ueda K, Saichi N, Takami S et al. A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS One6(4), e18567 (2011).
   Google Scholar
• Elschenbroich S, Ignatchenko V, Clarke B et al. In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry. J. Proteome Res.10(5), 2286–2299 (2011).
   PubMed Web of Science ®Google Scholar
• Cho CK, Drabovich AP, Batruch I, Diamandis EP. Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay. J. Proteomics74(10), 2052–2059 (2011).
   PubMed Web of Science ®Google Scholar
• Drabovich AP, Jarvi K, Diamandis EP. Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay. Mol. Cell. Proteomics10(12), M110.004127 (2011).
   PubMed Web of Science ®Google Scholar
• Ludwig C, Claassen M, Schmidt A, Aebersold R. Estimation of absolute protein quantities of unlabeled samples by selected reaction monitoring mass spectrometry. Mol. Cell. Proteomics11(3), M111.013987 (2011).
   PubMed Web of Science ®Google Scholar